Skip to main content
SpringerLink
Log in

Impfungen und Krebserkrankungen

  • Chapter
  • First Online:
Book cover Onkologische Rehabilitation

  • 2035 Accesses

Zusammenfassung

Personen mit Krebserkrankungen sind aufgrund ihrer Erkrankung und Therapie anfälliger für Infektionskrankheiten. Prophylaktische Impfungen können impf-präventable Infektionserkrankungen verhindern bzw. deren Verlauf abmildern. Die Wirksamkeit von Impfungen kann jedoch bei KrebspatientInnen wegen der veränderten Immunitätslage und besonders durch die Therapie eingeschränkt sein. Deswegen sollte der Impfstatus möglichst vor Therapieeinleitung überprüft und vervollständigt werden. Gleichzeitig sollen auch enge Bezugspersonen in die Impfberatung miteinbezogen werden, um die PatientInnen indirekt zu schützen. In Abhängigkeit, ob Lebend- oder Totimpfstoffe indiziert sind, gilt es gewisse Intervalle vor und nach Therapie einzuhalten. Während einer Chemotherapie sind Lebendimpfstoffe gänzlich kontraindiziert, Totimpfstoffe hingegen können verabreicht werden, wenngleich mit einer geringeren Wirksamkeit zu rechnen ist.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Abbas A, Lichtman A, Pillai S (2018) Cellular and molecular immunology, 9. Aufl. Saunders, Canada

    Google Scholar 

  • Almirall J, Serra-Prat M, Bolibar I, Balasso V (2017) Risk factors for community-acquired pneumonia in adults: a systematic review of observational studies respiration. International review of thoracic diseases 94:299–311

    PubMed  Google Scholar 

  • Alwarawrah Y, Kiernan K, MacIver NJ (2018) Changes in nutritional status impact immune cell metabolism and function. Front Immunol 9:1055

    PubMed  PubMed Central  Google Scholar 

  • Ariza-Heredia EJ, Chemaly RF (2015) Practical review of immunizations in adult patients with cancer. Hum Vaccin Immunother 11:2606–2614

    PubMed  PubMed Central  Google Scholar 

  • Backhaus E, Berg S, Andersson R et al (2016) Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factors. BMC Infect Dis 16:367

    PubMed  PubMed Central  Google Scholar 

  • Baden LR, Swaminathan S, Angarone M et al (2016) Prevention and treatment of cancer-related infections, version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 14(7):882–913

    CAS  PubMed  Google Scholar 

  • BAG u. EKIF (2014a) Empfehlungen zur Impfung von Empfängerinnen und Empfängern von Blut-Stammzellen. Bull BAG 2012; 21:363–370 (angepasst Januar 2014)

    Google Scholar 

  • BAG u. EKIF (2014b) Pneumokokkenimpfung: Empfehlungen zur Verhinderung von invasiven Pneumokokkenerkrankungen bei Risikogruppen. Bull BAG 8:129–141.

    Google Scholar 

  • BAG u. EKIF (2018) Schweizerischer Impfplan 2018. www.bag.admin.ch/impfplan

    Google Scholar 

  • Bastola R, Noh G, Keum T et al (2017) Vaccine adjuvants: smart components to boost the immune system. Arch Pharm Res 40:1238–1248

    CAS  PubMed  Google Scholar 

  • Bektas O, Karadeniz C, Oguz A, Berberoglu S, Yilmaz N, Citak C (2007) Assessment of the immune response to trivalent split influenza vaccine in children with solid tumors. Pediatr Blood Cancer 49:914–917

    PubMed  Google Scholar 

  • Berghmans T, Sculier JP, Klastersky J (2003) A prospective study of infections in lung cancer patients admitted to the hospital. Chest 124:114–120

    PubMed  Google Scholar 

  • Berglund A, Willen L, Grodeberg L, Skattum L, Hagberg H, Pauksens K (2014) The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximab. Acta Oncol 53:1212–1220

    CAS  PubMed  Google Scholar 

  • Berkowitz EM, Moyle G, Stellbrink HJ et al (2015) Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1/2a randomized, placebo-controlled study. J Infect Dis 211:1279–1287

    CAS  PubMed  Google Scholar 

  • Bitterman R, Eliakim-Raz N et al (2018) Influenza vaccines in immunosuppressed adults with cancer. Cochrane Database Syst Rev 2:CD008983. https://doi.org/10.1002/14651858.CD008983.pub3

    Article  PubMed  Google Scholar 

  • Briere EC, Rubin L, Moro PL et al (2014) Prevention and control of haemophilus influenzae type b disease: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 63(RR-01):1–14

    PubMed  Google Scholar 

  • CDC (2018) Seasonal Influenza Vaccine Effectiveness, 2004–2018. https://www.cdc.gov/flu/professionals/vaccination/effectiveness-studies.htm. Zugegriffen am 16.10.2018

  • Chiou WY, Hung SK, Lai CL et al (2015) Effect of 23-valent pneumococcal polysaccharide vaccine inoculated during anti-cancer treatment period in elderly lung cancer patients on community-acquired pneumonia hospitalization: a nationwide population-based cohort study. Medicine 94(26):e1022

    PubMed  PubMed Central  Google Scholar 

  • Chou JF, Kernan NA, Prockop S et al (2011) Safety and immunogenicity of the live attenuated varicella vaccine following T replete or T cell-depleted related and unrelated allogeneic hematopoietic cell transplantation (alloHCT). Biol Blood Marrow Transplant 17(11):1708–1713

    CAS  PubMed  PubMed Central  Google Scholar 

  • Conrad A, Alcazer V, Valour F, Ader F, Lyon HSG (2018) Vaccination post-allogeneic hematopoietic stem cell transplantation: what is feasible? Expert Rev Vaccines 17:299–309

    CAS  PubMed  Google Scholar 

  • Cordonnier C, Labopin M, Chesnel V et al (2010) Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trial. Vaccine 28:2730–2734

    CAS  PubMed  Google Scholar 

  • Cordonnier C, Ljungman P, Juergens C et al (2015) Immunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged >/=2 years: an open-label study. Clin Infect Dis 61(3):313–323

    CAS  PubMed  PubMed Central  Google Scholar 

  • Cunningham AL, Lal H, Kovac M et al (2016) Efficacy of the Herpes Zoster subunit vaccine in adults 70 years of age or older. N Engl J Med 375(11):1019–1032

    CAS  PubMed  Google Scholar 

  • Derosa L, Hellmann MD, Spaziano M et al (2018) Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer. Ann Oncol 29(6):1437–1444

    CAS  PubMed  PubMed Central  Google Scholar 

  • Dooling K-L, Guo A, Patel M et al (2018) Recommendations of the advisory committee on immunization practices for use of Herpes Zoster Vaccines. MMWR 67:103–108

    PubMed  Google Scholar 

  • Dreyer S, Hemarajata P, Hogeling M, Henderson GP (2017) Pediatric vaccine-strain herpes zoster: a case series. Pediatr Dermatol 34:665–667

    PubMed  Google Scholar 

  • ECDC (2018) Monthly measles and rubella monitoring report, August 2018. https://ecdc.europa.eu/sites/portal/files/documents/measles-and-rubella-monitoring-report-Sep-2018.pdf. Zugegriffen am 16.10.2018

  • Empfehlung zur jährlichen Influenza-Impfung („Grippeimpfung“) (2017). https://www.bmgf.gv.at/cms/home/attachments/3/0/3/CH1100/CMS1507802512474/influenza_stellungnahme.pdf. Zugegriffen am 16.10.2018

  • Esposito S, Cecinati V, Brescia L, Principi N (2010) Vaccinations in children with cancer. Vaccine 28:3278–3284

    CAS  PubMed  Google Scholar 

  • Goossen GM, Kremer LC, van de Wetering MD (2013) Influenza vaccination in children being treated with chemotherapy for cancer. Cochrane Database Syst Rev:CD006484

    Google Scholar 

  • Greenberg RN, Gurtman A, Frenck RW et al (2014) Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults 60–64 years of age. Vaccine 32:2364–2374

    CAS  PubMed  Google Scholar 

  • Hansson E, Forbes HJ, Langan SM, Smeeth L, Bhaskaran K (2017) Herpes zoster risk after 21 specific cancers: population-based case-control study. Br J Cancer 116:1643–1651

    PubMed  PubMed Central  Google Scholar 

  • Harris AE, Styczynski J, Bodge M, Mohty M, Savani BN, Ljungman P (2015) Pretransplant vaccinations in allogeneic stem cell transplantation donors and recipients: an often-missed opportunity for immunoprotection? Bone Marrow Transplant 50:899–903

    CAS  PubMed  Google Scholar 

  • Hilgendorf I, Freund M, Jilg W et al (2011) Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GVHD. Vaccine 29:2825–2833

    PubMed  Google Scholar 

  • Impfplan Österreich (2018). https://www.bmgf.gv.at/cms/home/attachments/3/3/1/CH1100/CMS1515753153756/impfplan_2018.pdf. Zugegriffen am 16.10.2018

  • Jaffe D, Papadopoulos EB, Young JW et al (2006) Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants. Blood 108:2470–2475

    CAS  PubMed  PubMed Central  Google Scholar 

  • José R, Mohammed A, Goldring J, Chambers R, Brwon J, Agarwal B (2015) Cancer patients with community-acquired pneumonia treated in intensive care have poorer outcomes associated with increased illness severity and septic shock at admission to intensive care: a retrospective cohort study. Pneumonia 6:77–82

    PubMed  PubMed Central  Google Scholar 

  • Kawamura K, Yamazaki R, Akahoshi Y et al (2015) Evaluation of the immune status against measles, mumps, and rubella in adult allogeneic hematopoietic stem cell transplantation recipients. Hematology 20:77–82

    CAS  PubMed  Google Scholar 

  • Kotecha RS, Wadia DU, Jacoby P et al (2016) Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer. Cancer Med 5:285–293

    CAS  PubMed  Google Scholar 

  • Kumar D, Chen MH, Welsh B et al (2007) A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients. Clin Infect Dis 45:1576–1582

    PubMed  Google Scholar 

  • Kumar D, Humar A, Plevneshi A et al (2008) Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance. Bone Marrow Transplant 41:743–747

    CAS  PubMed  Google Scholar 

  • Kunisaki KM, Janoff EN (2009) Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 9:493–504

    PubMed  PubMed Central  Google Scholar 

  • Kwon HJ, Lee JW, Chung NG, Cho B, Kim HK, Kang JH (2012) Assessment of serologic immunity to diphtheria-tetanus-pertussis after treatment of Korean pediatric hematology and oncology patients. J Korean Med Sci 27:78–83

    CAS  PubMed  Google Scholar 

  • Lal H, Cunningham AL, Godeaux O et al (2015) Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med 372:2087–2096

    PubMed  Google Scholar 

  • Laubli H, Balmelli C, Kaufmann L et al (2018) Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events. J Immunother Cancer 6:40

    PubMed  PubMed Central  Google Scholar 

  • Lee HY, Hsieh YC, Liu CC et al (2018) Invasive pneumococcal pneumonia caused by 13-valent pneumococcal conjugate vaccine types in children with different schedules. J Microbiol Immunol Infect 51(2):199–206

    PubMed  Google Scholar 

  • Ljungman P, Nahi H, Linde A (2005) Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study. Br J Haematol 130:96–98

    PubMed  Google Scholar 

  • Ljungman P, Cordonnier C, Einsele H et al (2009) Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant 44(8):521–526

    CAS  PubMed  Google Scholar 

  • Lopez A, Mariette X, Bachelez H et al (2017) Vaccination recommendations for the adult immunosuppressed patient: a systematic review and comprehensive field synopsis. J Autoimmun 80:10–27

    PubMed  Google Scholar 

  • Mahler MB, Taur Y, Jean R, Kernan NA, Prockop SE, Small TN (2012) Safety and immunogenicity of the tetravalent protein-conjugated meningococcal vaccine (MCV4) in recipients of related and unrelated allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 18:145–149

    CAS  PubMed  Google Scholar 

  • Mikati T, Taur Y, Seo SK, Shah MK (2013) International travel patterns and travel risks of patients diagnosed with cancer. J Travel Med 20:71–77

    PubMed  Google Scholar 

  • Nakashima K, Aoshima M, Ohfuji S et al (2017) Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy. Hum Vaccin Immunother 13:543–550

    PubMed  Google Scholar 

  • Natori Y, Humar A, Lipton J et al (2017) A pilot randomized trial of adjuvanted influenza vaccine in adult allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 52:1016–1021

    CAS  PubMed  Google Scholar 

  • Niehues T, Bogdan C, Hecht J, Mertens T, Wiese-Posselt M, Zepp F (2017) Impfen bei Immundefizienz. Bundesgesundheitsblatt:674–684

    Google Scholar 

  • Nilsson A, De Milito A, Engström P et al (2002) Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens. Pediatrics 109(6):e91

    PubMed  Google Scholar 

  • Rieger CT, Liss B, Mellinghoff S et al (2018) Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO). Ann Oncol 29:1354–1365

    CAS  PubMed  PubMed Central  Google Scholar 

  • RKI (2016) Wissenschaftliche Begründung für die Aktualisierung der Empfehlungen zur Indikationsimpfung gegen Pneumokokken für Risikogruppen. Epidemiologisches Bulletin 37/2016. https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2016/Ausgaben/37_16.pdf?__blob=publicationFile. Zugegriffen am 16.10.2018

  • RKI (2018) Empfehlungen der Ständigen Impfkommission (STIKO) beim Robert Koch-Institut – 2018/2019. https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2018/Ausgaben/34_18.pdf?__blob=publicationFile. Zugegriffen am 16.10.2018

  • Sanada Y, Yakushijin K, Nomura T et al (2016) A prospective study on the efficacy of two-dose influenza vaccinations in cancer patients receiving chemotherapy. Jpn J Clin Oncol 46:448–452

    PubMed  Google Scholar 

  • Sarmati L, Andreoni M, Antonelli G et al (2017) Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation-a position paper. Clin Microbiol Infect 23:935–940

    CAS  PubMed  Google Scholar 

  • Schuster MG, Cleveland AA, Dubberke ER et al (2017) Infections in hematopoietic cell transplant recipients: results from the organ transplant infection project, a multicenter, prospective, cohort study. Open Forum Infecti Dis 4:ofx050

    Google Scholar 

  • Seggewiss R, Einsele H (2010) Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update. Blood 115:3861–3868

    CAS  PubMed  Google Scholar 

  • Shanis D, Anandi P, Grant C et al (2018) Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study. Bone Marrow Transplant 53:78–83

    CAS  PubMed  Google Scholar 

  • Shetty AK, Winter MA (2012) Immunization of children receiving immunosuppressive therapy for cancer or hematopoietic stem cell transplantation. Ochsner J 12:228–243

    PubMed  PubMed Central  Google Scholar 

  • Shigayeva A, Rudnick W, Green K et al (2016) Invasive pneumococcal disease among immunocompromised persons: implications for vaccination programs. Clin Infect Dis 62:139–147

    PubMed  Google Scholar 

  • Steele RW (2012) Managing infection in cancer patients and other immunocompromised children. Ochsner J 12:202–210

    PubMed  PubMed Central  Google Scholar 

  • Suzuki M, Dhoubhadel BG, Ishifuji T et al (2017) Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study. Lancet Infect Dis 17:313–321

    CAS  PubMed  Google Scholar 

  • Svensson T, Kättsträm M, Hammarlund Y et al (2018) Pneumococcal conjugate vaccine triggers a better immune response than pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia A randomized study by the Swedish CLL group. Vaccine 36:3701–3707

    CAS  PubMed  Google Scholar 

  • Tomblyn M, Chiller T, Einsele H et al (2009) Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 15:1143–1238

    CAS  PubMed  PubMed Central  Google Scholar 

  • Torres A, Peetermans WE, Viegi G, Blasi F (2013) Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax 68:1057–1065

    PubMed  PubMed Central  Google Scholar 

  • Tsigrelis C, Ljungman P (2016) Vaccinations in patients with hematological malignancies. Blood Rev 30:139–147

    CAS  PubMed  Google Scholar 

  • van Veen KE, Brouwer MC, van der Ende A, van de Beek D (2016) Bacterial meningitis in hematopoietic stem cell transplant recipients: a population-based prospective study. Bone Marrow Transplant 51:1490–1495

    PubMed  Google Scholar 

  • Voican CS, Mir O, Loulergue P et al (2016) Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment. Ann Oncol 27:2172–2184

    CAS  PubMed  Google Scholar 

  • Vollaard A, Schreuder I, Slok-Raijmakers L, Opstelten W, Rimmelzwaan G, Gelderblom H (2017) Influenza vaccination in adult patients with solid tumours treated with chemotherapy. Eur J Cancer 76:134–143

    PubMed  Google Scholar 

  • Ward EM, Flowers CR, Gansler T, Omer SB, Bednarczyk RA (2017) The importance of immunization in cancer prevention, treatment, and survivorship. CA Cancer J Clin 67:398–410

    PubMed  Google Scholar 

  • Wiedermann U, Sitte HH, Burgmann H et al (2016) Guidelines for vaccination of immunocompromised individuals. Wien Klin Wochenschr 128(Suppl 4):337–376

    CAS  PubMed  Google Scholar 

  • Wiedermann-Schmidt U, Rendi-Wagner P, Aigner G, et al (2012) Impfungen für Mitarbeiter des Gesundheitswesens. https://www.meduniwien.ac.at/hp/fileadmin/tropenmedizin/DokumenteChristina/Impfempfehlungen_fuer_Gesundheitspersonal_s.pdf. Zugegriffen am 16.10.2018

  • Wiedermann-Schmidt U, Kollaritsch H, Bachinger G, et al (2013) Reaktionen und Nebenwirkungen nach Impfungen. https://www.bmgf.gv.at/cms/home/attachments/1/5/5/CH1100/CMS1386342769315/impfungen-reaktionen_nebenwirkungen.pdf. Zugegriffen am 16.10.2018

  • Winston DJ, Mullane KM, Cornely OA et al (2018) Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial. Lancet 391:2116–2127

    PubMed  Google Scholar 

  • Wumkes ML, van der Velden AM, Los M et al (2013) Serum antibody response to influenza virus vaccination during chemotherapy treatment in adult patients with solid tumours. Vaccine 31:6177–6184

    CAS  PubMed  Google Scholar 

  • Yri OE, Torfoss D, Hungnes O et al (2011) Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment. Blood 118:6769–6771

    CAS  PubMed  Google Scholar 

  • Zengin E, Sarper N (2009) Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination. Pediatr Blood Cancer 53:967–972

    PubMed  Google Scholar 

  • Zignol M, Peracchi M, Tridello G et al (2004) Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Cancer 101:635–641

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Spezifische Prophylaxe und Tropenmedizin, Medizinische Universität Wien, Wien, Österreich

    Angelika Wagner & Ursula Wiedermann-Schmidt

Authors
  1. Angelika Wagner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ursula Wiedermann-Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Angelika Wagner .

Editor information

Editors and Affiliations

  1. Universitätsklinik für Physikalische Medizin, Rehabilitation und Arbeitsmedizin, Medizinische Universität Wien, Wien, Austria

    Richard Crevenna

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wagner, A., Wiedermann-Schmidt, U. (2020). Impfungen und Krebserkrankungen. In: Crevenna, R. (eds) Onkologische Rehabilitation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-57982-4_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-57982-4_15

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-57981-7

  • Online ISBN: 978-3-662-57982-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation